Scarica l'app Stockscreener
3.62
3.47%
-0.13
Dopo l'orario di chiusura:
3.61
-0.01
-0.28%
Medicus Pharma Ltd Borsa (MDCX) Ultime notizie
Will Medicus' D-MNA Prove To Be A Non-Invasive, Effective Alternative To Mohs Surgery For BCC? - RTTNews
Medicus Pharma Ltd. SEC 10-K Report - TradingView
Medicus Pharma Ltd. (MDCX) reports earnings - Quartz
Healthcare Disruptors: AI, Telehealth and Cost Savings - Value The Markets
ValueTheMarkets Insights: While Big Pharma Stalls, One Small-Cap Breaks Out - WRAL.com
ValueTheMarkets Insights: Healthcare Climbs as Tech Stumbles in 2025 Shift - WRAL.com
Healthcare Climbs as Tech Stumbles in 2025 Shift - Value the Markets
While Big Pharma Stalls, One Small-Cap Breaks Out - Value the Markets
Medicus Pharma cancels shareholder meeting notice By Investing.com - Investing.com Australia
Medicus Pharma cancels shareholder meeting notice - Investing.com
Pinpointing Hidden Stock Winners in a Volatile Market - Value the Markets
3 US Healthcare Stocks That Might Be Undervalued 2025 - Value The Markets
Medicus Pharma Share Price: MDCX Stock Closed Up 15.35%! - Value The Markets
Medicus Pharma announces annual meeting date - Investing.com
Medicus Pharma announces annual meeting date By Investing.com - Investing.com Australia
Advancing Oncology: Innovations in Treatment and Detection - Value The Markets
See Why Some Investors Are Watching This Biotech Company - Value The Markets
Biotech Stock Tapping $7B+ Skin Cancer Market Opportunity - Value The Markets
The Biotech Stocks Tackling the World’s Most Common Cancer - Value The Markets
Medicus Pharma - The Pharma Letter
Medicus Pharma Secures $4.2 Million for Innovative Skin Treatment Trials - TipRanks
Medicus Pharma Ltd. Announces Closing of $4.2 Million Regulation A Offering - Newsfile
Medicus Pharma CEO discusses latest skin cancer trial resultsICYMI - Proactive Investors UK
Encouraging Interim Data for Innovative Skin Cancer Patch - Value The Markets
Small cap wrap: G Mining Ventures, Wedgemount Resources, Medicus Pharma... - Proactive Investors UK
Medicus Pharma Ltd: Promising Phase 2 Results and Market Potential Drive Buy Rating - TipRanks
Medicus Pharma unveils pricing of financing to advance skin cancer treatment - Proactive Investors Australia
Can This $4.2M Funding Advance Medicus Pharma's Novel Skin Cancer Patch to Market? - StockTitan
Medicus Pharma Ltd. Announces Pricing of $4.2 Million Regulation A Offering - Newsfile
Clinical Study SKNJCT-003 shows positive trends as company advances skin cancer research in UAE - Proactive Investors USA
Small cap wrap: Petro-Victory Energy, NexTech3D.ai, Medicus Pharma, Nano One Technology... - Proactive Investors UK
Market movers: Tesla, Marvell, Petro-Victory, Medicus Pharma... - Proactive Investors USA
Interim Data Update from Medicus Pharma’s Phase 2 Clinical Trial - Value the Markets
High Demand, Few Options: The Skin Cancer Treatment Gap - Value The Markets
Medicus Pharma reports over 60% complete clearance in Phase 2 BCC trial interim results - Proactive Investors Australia
Medicus Pharma Announces Positively Trending Interim Analysis For SKNJCT-003 Phase 2 Clinical Study - Marketscreener.com
Medicus Pharma announces positively trending interim analysis for SKNJCT-003 - TipRanks
Medicus Pharma Ltd Announces Positively Trending Interim Analysis for SKNJCT-003 Phase 2 Clinical Study to Non-Invasively Treat Basal Cell Carcinoma of the Skin (BCC) - GlobeNewswire
Can This New Skin Cancer Treatment Replace Surgery? Phase 2 Trial Reveals Promising Results - StockTitan
A Breakthrough in Non-Invasive Skin Cancer Treatment - Value The Markets
Why Reddit Stock Lost 19% in February - The Globe and Mail
Sea (SE) Reports Q4: Everything You Need To Know Ahead Of Earnings - The Globe and Mail
Prediction: 3 Stocks That'll Be Worth More Than Apple 5 Years From Now - The Globe and Mail
Extended Session Rally For Medicus (MDCX) Stock, Fueled By Regulatory Success - Stocks Telegraph
Medicus Pharma Ltd Announces Submission of Phase 2 Clinical - GlobeNewswire
Medicus Pharma Submits Phase 2 Clinical Trial Design For Non-Invasive BCC Treatment To UAE - Nasdaq
Small cap headlines: Alvopetro Energy, Delivra Health, Medicus Pharma, Aftermath Silver... - Proactive financial news
Medicus Pharma expands basal cell carcinoma trial in the Middle East - Proactive Investors Australia
Market movers: Ideal Power, Tiziana Life Sciences, Medicus Pharma... - Proactive financial news
Medicus Pharma submits Phase 2 carcinoma clinical design in UAE - TipRanks
Medicus Pharma submits Phase 2 skin cancer trial design to UAE Department of Health - Proactive Investors Australia
Medicus Pharma Submits Phase 2 Clinical Design for Skin Cancer Treatment in UAE - TipRanks
Medicus Pharma advances skin cancer treatment study By Investing.com - Investing.com Canada
Medicus Pharma advances skin cancer treatment study - Investing.com India
Medicus Pharma Advances Non-Invasive Skin Cancer Treatment in UAE - TipRanks
Medicus Pharma Ltd Announces Submission of Phase 2 Clinical Design (SKNJCT-004) to UAE Department of Health (DOH) to Non-Invasively Treat Basal Cell Carcinoma of the Skin (BCC) - Malay Mail
10.70%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):